129 related articles for article (PubMed ID: 12890163)
1. Variable manifestation in natural killer cell leukaemia.
Kuroda J; Kimura S; Kobayashi Y; Jyoko N; Kamitsuji Y; Murotani Y; Fukuda W; Akaogi T; Hayashi H; Yoshikawa T; Maekawa T
Clin Lab Haematol; 2003 Aug; 25(4):239-45. PubMed ID: 12890163
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
3. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
4. A new human natural killer leukemia cell line, IMC-1. A complex chromosomal rearrangement defined by spectral karyotyping: functional and cytogenetic characterization.
Chen IM; Whalen M; Bankhurst A; Sever CE; Doshi R; Hardekopf D; Montgomery K; Willman CL
Leuk Res; 2004 Mar; 28(3):275-84. PubMed ID: 14687623
[TBL] [Abstract][Full Text] [Related]
5. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.
DiGiuseppe JA; Louie DC; Williams JE; Miller DT; Griffin CA; Mann RB; Borowitz MJ
Am J Surg Pathol; 1997 Oct; 21(10):1223-30. PubMed ID: 9331296
[TBL] [Abstract][Full Text] [Related]
6. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
Suzuki R; Nakamura S
Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
[TBL] [Abstract][Full Text] [Related]
7. Acute lymphoblastic leukemia/lymphoblastic lymphoma of natural killer (NK) lineage: quest for another NK-lineage neoplasm.
Nakamura F; Tatsumi E; Kawano S; Tani A; Kumagai S; Nishikori M; Nagai T
Blood; 1997 Jun; 89(12):4665-6. PubMed ID: 9192799
[No Abstract] [Full Text] [Related]
8. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
[TBL] [Abstract][Full Text] [Related]
9. Blastic natural killer-cell lymphoma: a case report.
Wilentz SE
Cutis; 2006 Jan; 77(1):42-4. PubMed ID: 16475495
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic classification of acute lymphoblastic leukaemia.
Ludwig WD; Raghavachar A; Thiel E
Baillieres Clin Haematol; 1994 Jun; 7(2):235-62. PubMed ID: 7803900
[No Abstract] [Full Text] [Related]
11. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells.
Suzuki R; Suzumiya J; Nakamura S; Aoki S; Notoya A; Ozaki S; Gondo H; Hino N; Mori H; Sugimori H; Kawa K; Oshimi K;
Leukemia; 2004 Apr; 18(4):763-70. PubMed ID: 14961041
[TBL] [Abstract][Full Text] [Related]
12. [Retrospective analysis of 4 cases of the so-called blastic NK-cell lymphoma, with reference to the 2008 WHO classification of tumours of haematopoietic and lymphoid tissues].
Zheng YY; Chen G; Zhou XG; Jin Y; Xie JL; Zhang SH; Zhang YN
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):600-5. PubMed ID: 21092587
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic findings in acute biphenotypic leukaemia.
Carbonell F; Swansbury J; Min T; Matutes E; Farahat N; Buccheri V; Morilla R; Secker-Walker L; Catovsky D
Leukemia; 1996 Aug; 10(8):1283-7. PubMed ID: 8709632
[TBL] [Abstract][Full Text] [Related]
14. Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma.
Kimura S; Kakazu N; Kuroda J; Akaogi T; Hayashi H; Nishida K; Abe T
Ann Hematol; 2001 Apr; 80(4):228-31. PubMed ID: 11401089
[TBL] [Abstract][Full Text] [Related]
15. Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis.
Hanson CA; Abaza M; Sheldon S; Ross CW; Schnitzer B; Stoolman LM
Br J Haematol; 1993 May; 84(1):49-60. PubMed ID: 7687860
[TBL] [Abstract][Full Text] [Related]
16. Peroxidase-negative and myelomonocytic antigen-positive acute leukemia.
Okawa H; Nagasawa M; Morio T; Takase K; Tanaka K; Yata J; Dan K; Nomura T; Sakamaki H; Onozawa Y
Int J Hematol; 1992 Apr; 55(2):165-71. PubMed ID: 1324747
[TBL] [Abstract][Full Text] [Related]
17. Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
Alvarez-Larrán A; Villamor N; Hernández-Boluda JC; Ferrer A; Camós M; Campo E; López-Guillermo A
Clin Lymphoma; 2001 Dec; 2(3):178-82; discussion 183-4. PubMed ID: 11779295
[TBL] [Abstract][Full Text] [Related]
18. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement.
Nagata T; Higashigawa M; Nagai M; Zhang XL; Azuma E; Komada Y; Sakurai M
Leuk Res; 1996; 20(11-12):983-5. PubMed ID: 9009257
[TBL] [Abstract][Full Text] [Related]
19. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
[TBL] [Abstract][Full Text] [Related]
20. Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.
Li Y; Wei J; Mao X; Gao Q; Liu L; Cheng P; Liu L; Zhang X; Zhang K; Wang J; Zhu L; Zhou J; Zhang Y; Meng L; Sun H; Li D; Huang M; Huang W; Deng J; Zhang D
PLoS One; 2016; 11(8):e0158827. PubMed ID: 27483437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
